Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-11
2006-04-11
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S081000, C514S232800, C544S126000
Reexamination Certificate
active
07026331
ABSTRACT:
The subject matter of the present invention is directed to novel substituted beta-carbolines, and specifically compounds of the formula I,which are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of IκB kinase is involved.
REFERENCES:
patent: 4631149 (1986-12-01), Rinehart, Jr. et al.
patent: 4731358 (1988-03-01), Huth et al.
patent: 5532261 (1996-07-01), DiNinno et al.
patent: 5604236 (1997-02-01), Jakubowski et al.
patent: 5854003 (1998-12-01), Rothe et al.
patent: 6627637 (2003-09-01), Ritzeler et al.
patent: 568 675 (1933-01-01), None
patent: 198 07 993 (1999-09-01), None
patent: 0 110 814 (1984-06-01), None
patent: 0 133 000 (1985-02-01), None
patent: 0 667 347 (1995-08-01), None
patent: 1 048 666 (2000-11-01), None
Hagen et al, Journal of Medicinal Chemistry, vol. 30, pp. 750-753, 1987.
Agarwal et al, Med Chemi Res, vol. 3, pp. 523-530, 1994.
K. Smith et al., “A New Method for Bromination of Carbazoles, β-Carbolines and Iminodibenzyls by Use of N-Bromosuccinimide and Silica Gel,” Tetrahedron, vol. 48, No. 36, pp. 7479-7488 (1992).
Chemical Abstract, vol. 121, No. 7, XP-002165154, Columbus, Ohio (Aug. 15, 1994).
Chemical Abstract, vol. 122, No. 19, XP-002165155, Columbus, Ohio (May 8, 1995).
Chemical Abstract, vol. 121, No. 3, XP-002165156, Columbus, Ohio (Jul. 18, 1994).
Chemical Abstract, vol. 106, No. 23, XP-002165157, Columbus, Ohio (Jun. 8, 1987).
Chemical Abstract, vol. 74, No. 1, XP-002165158, Columbus, Ohio (Jan. 4, 1971).
Chemical Abstract, vol. 92, No. 25, XP-002165159, Columbus, Ohio (Jun. 23, 1980).
C. Coulthard et al., “XCVI. The Chemotherapy of Derivatives of Harmine and Harmaline I,” Biochemical Journal, Portland Press, vol. 27, No. 3, pp. 727-739, XP-000917474, ISSN: 0264-6021 (1933).
R. Konowalowa et al., “Untersuchungen in der Reihe des Harmins und Harmalins. 2.Mitteilung1): Nitro=und Aminoderivate des Harmins und Harmalins, O=Alkyläther des Harmols und Harmalols,” vol. 273, pp. 156-163 (Nov. 1934) XP000917794.
6001 Chemical Abstract, vol. 96, No. 9, XP-002170075, Columbus, Ohio (Mar. 1, 1982).
Database RTECS 'Online, RTECS No. UU9354600, XP-002170076, Abstract (Jul. 1986).
A. Agarwal et al., “Structure-Antifilarial Activity Relationship of 5/6/7/8-Mono- or Disubstituted 1H/1-Phenyl-9 H-pyridol[3,4-b]indoles—A New Class of Potential Filaricides,” Natur. Section C, vol. 49, No. 7/8, pp. 526-529 (1994).
Adams Julian
Castro Alfredo
Grenier Louis
Hancock Wayne W.
Mazdiyasni Hormoz
Davis Zinna Northington
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Sanofi-Aventis Deutschland GmbH
LandOfFree
Substituted beta-carbolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted beta-carbolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted beta-carbolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3609709